» Articles » PMID: 36111710

[Clinical Features and Epidemiological Significance of Pertussis in Infants]

Overview
Specialty Pediatrics
Date 2022 Sep 16
PMID 36111710
Authors
Affiliations
Soon will be listed here.
Abstract

Infantile pertussis is clear evidence for the persistent transmission of pertussis in communities. Infants are the most vulnerable population for pertussis infection and are also important nodes in pertussis transmission networks in communities, and therefore, the prevention of infantile pertussis is the core of prevention and control measures against pertussis including vaccine immunization. Although the cases of pertussis reported in China are mainly infants with pertussis, the actual number of infants with pertussis might be higher than the reported number. It is necessary in clinical practice to improve the awareness of this disease and promote related laboratory tests. On the basis of emphasizing the identification of pertussis in infants, timely diagnosis and treatment, follow-up visits, and standard management of the close contacts of infants with pertussis should be performed to reduce and block the community transmission of pertussis.

References
1.
. [Recommendation for diagnosis and treatment of Chinese children with pertussis]. Zhonghua Er Ke Za Zhi. 2017; 55(8):568-572. DOI: 10.3760/cma.j.issn.0578-1310.2017.08.004. View

2.
Gabutti G, Cetin I, Conversano M, Costantino C, Durando P, Giuffrida S . Experts' Opinion for Improving Pertussis Vaccination Rates in Adolescents and Adults: A Call to Action. Int J Environ Res Public Health. 2022; 19(7). PMC: 8998413. DOI: 10.3390/ijerph19074412. View

3.
Meng Q, Liu Y, Yu J, Li L, Shi W, Shen Y . Seroprevalence of Maternal and Cord Antibodies Specific for Diphtheria, Tetanus, Pertussis, Measles, Mumps and Rubella in Shunyi, Beijing. Sci Rep. 2018; 8(1):13021. PMC: 6115429. DOI: 10.1038/s41598-018-31283-y. View

4.
Tang Q, Gan C, Wu X, Xu H, Zhang Z . [Effect of pertussis vaccination on clinical manifestations of infants and young children with pertussis]. Zhongguo Dang Dai Er Ke Za Zhi. 2021; 23(2):138-142. PMC: 7921537. View

5.
Cimolai N . Pharmacotherapy for Bordetella pertussis infection. II. A synthesis of clinical sciences. Int J Antimicrob Agents. 2020; 57(3):106257. DOI: 10.1016/j.ijantimicag.2020.106257. View